Interestingly, a 2024 study presented at the Endocrine Society's annual meeting evaluating 638,501 patients with a history of acute pancreatitis suggested that GLP‐1 RAs reduce the risk of recurrent acute pancreatitis [23]. This evidence concerns the gene GLP1R and acute pancreatitis.